GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (OTCPK:CSBTF) » Definitions » Current Deferred Revenue

CSBTF (Kuros Biosciences) Current Deferred Revenue : $0.00 Mil (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Kuros Biosciences Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Kuros Biosciences's current deferred revenue for the quarter that ended in Jun. 2024 was $0.00 Mil.

Kuros Biosciences Current Deferred Revenue Historical Data

The historical data trend for Kuros Biosciences's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Current Deferred Revenue Chart

Kuros Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kuros Biosciences Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kuros Biosciences Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuros Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (OTCPK:CSBTF) » Definitions » Current Deferred Revenue
Comparable Companies
XSWX:MED XSWX:MOVE ABT SYK BSX MDT XTER:SHL SZSE:300760 EW XAMS:PHIA DXCM STE XSWX:SOON ZBH PODD SHSE:688271 LSE:SN. ASX:COH GMED BIO
Traded in Other Exchanges
KURNz:UK 0RHR:UK KURN:Switzerland
Address
Wagistrasse 25, Schlieren, Zurich, CHE, 8952
Website
https://www.kurosbio.com
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.